A Study of Prexasertib (LY2606368) in Participants With Advanced Cancer

I4D-EW-JTJG -

The main purpose of this study is to evaluate the safety of the study drug known as LY2606368 in participants with advanced cancer or cancer that has spread to other parts of the body.

Trial Summary

Age Range
≥18 years
Conditions the trial is for
Advanced Cancer
What the trial is testing?
Prexasertib
Could I receive a Placebo?
No
Enrollment Goal
6
Trial Dates
Sep 22, 2016 - Jul 27, 2017
How long will I be in the trial?
Your participation could last up to 5 weeks depending on how you and your tumor respond.
Trial Phase
I

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.